11/12
02:41 pm
asrt
Quetzal Therapeutics Appoints Todd Smith as Board Member [Yahoo! Finance]
Low
Report
Quetzal Therapeutics Appoints Todd Smith as Board Member [Yahoo! Finance]
11/11
04:21 am
asrt
Assertio Holdings Inc (ASRT) Q3 2025 Earnings Call Highlights: Impressive Growth Amid Market ... [Yahoo! Finance]
High
Report
Assertio Holdings Inc (ASRT) Q3 2025 Earnings Call Highlights: Impressive Growth Amid Market ... [Yahoo! Finance]
11/10
06:22 pm
asrt
Assertio Holdings, Inc. (ASRT) Q3 2025 Earnings Call Transcript [Seeking Alpha]
Medium
Report
Assertio Holdings, Inc. (ASRT) Q3 2025 Earnings Call Transcript [Seeking Alpha]
11/10
04:56 pm
asrt
Assertio stock rises after revenue beat [Seeking Alpha]
Medium
Report
Assertio stock rises after revenue beat [Seeking Alpha]
11/10
04:38 pm
asrt
Assertio Reports Third Quarter 2025 Financial Results [Yahoo! Finance]
Medium
Report
Assertio Reports Third Quarter 2025 Financial Results [Yahoo! Finance]
11/10
04:13 pm
asrt
Assertio Reports Third Quarter 2025 Financial Results
Medium
Report
Assertio Reports Third Quarter 2025 Financial Results
10/28
09:15 am
asrt
Assertio Announces Leadership Transition
Low
Report
Assertio Announces Leadership Transition
10/24
12:16 pm
asrt
Assertio (NASDAQ:ASRT) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Assertio (NASDAQ:ASRT) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
10/3
03:30 pm
asrt
Assertio (NASDAQ:ASRT) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Assertio (NASDAQ:ASRT) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
9/23
08:36 am
asrt
CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Spectrum Pharmaceuticals (NASDAQ: SPPI) Investors to Inquire About a Securities Fraud Class Action by September 24, 2025
Low
Report
CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Spectrum Pharmaceuticals (NASDAQ: SPPI) Investors to Inquire About a Securities Fraud Class Action by September 24, 2025
9/23
07:03 am
asrt
New Strong Sell Stocks for September 23rd [Yahoo! Finance]
Low
Report
New Strong Sell Stocks for September 23rd [Yahoo! Finance]
9/21
11:23 am
asrt
Spectrum Pharmaceuticals (SPPI) and Assertio Holdings (ASRT) Investor Alert: 3-DAY DEADLINE in Securities Lawsuit– Hagens Berman
Low
Report
Spectrum Pharmaceuticals (SPPI) and Assertio Holdings (ASRT) Investor Alert: 3-DAY DEADLINE in Securities Lawsuit– Hagens Berman
9/15
09:16 am
asrt
Assertio Presents First-Ever Real-World Study Showing Patient Experience with SYMPAZAN® (clobazam) Oral Film, CIV [Yahoo! Finance]
Low
Report
Assertio Presents First-Ever Real-World Study Showing Patient Experience with SYMPAZAN® (clobazam) Oral Film, CIV [Yahoo! Finance]
9/15
09:00 am
asrt
Assertio Presents First-Ever Real-World Study Showing Patient Experience with SYMPAZAN® (clobazam) Oral Film, CIV
Low
Report
Assertio Presents First-Ever Real-World Study Showing Patient Experience with SYMPAZAN® (clobazam) Oral Film, CIV
9/12
11:51 am
asrt
DEADLINE APPROACHING: Berger Montague Advises Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) Investors to Inquire About a Securities Fraud Class Action by September 24, 2025
Low
Report
DEADLINE APPROACHING: Berger Montague Advises Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) Investors to Inquire About a Securities Fraud Class Action by September 24, 2025
9/10
07:44 am
asrt
Assertio to Present New Data from Real-World Evidence Study of SYMPAZAN® at upcoming 150th Annual Meeting of the American Neurological Association [Yahoo! Finance]
Low
Report
Assertio to Present New Data from Real-World Evidence Study of SYMPAZAN® at upcoming 150th Annual Meeting of the American Neurological Association [Yahoo! Finance]
9/10
07:30 am
asrt
Assertio to Present New Data from Real-World Evidence Study of SYMPAZAN® at upcoming 150th Annual Meeting of the American Neurological Association
Low
Report
Assertio to Present New Data from Real-World Evidence Study of SYMPAZAN® at upcoming 150th Annual Meeting of the American Neurological Association
9/8
05:39 pm
asrt
SPECTRUM PHARMACEUTICALS (NASDAQ: SPPI) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Class Action by September 24, 2025
Low
Report
SPECTRUM PHARMACEUTICALS (NASDAQ: SPPI) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Class Action by September 24, 2025